ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 2 filers reported holding ONCOCYTE CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $230 | -35.2% | 1,000 | 0.0% | 0.00% | – |
| Q1 2023 | $355 | +10.6% | 1,000 | 0.0% | 0.00% | – |
| Q4 2022 | $321 | -67.9% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $2,000 | -50.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $4,000 | -33.3% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $6,000 | +20.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $5,000 | +150.0% | 1,000 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $2,000 | +100.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $2,000 | -66.7% | 1,000 | -66.7% | 0.00% | -66.7% |
| Q3 2019 | $6,000 | -25.0% | 3,000 | -9.1% | 0.00% | -25.0% |
| Q2 2019 | $8,000 | -38.5% | 3,300 | 0.0% | 0.00% | -55.6% |
| Q1 2019 | $13,000 | – | 3,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 14,716,204 | $20,456,000 | 1.61% |
| PURA VIDA INVESTMENTS, LLC | 6,022,534 | $8,371,000 | 0.43% |
| P.A.W. CAPITAL CORP | 199,700 | $278,000 | 0.30% |
| Penbrook Management LLC | 229,425 | $319,000 | 0.28% |
| PERKINS CAPITAL MANAGEMENT INC | 39,725 | $55,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 201,047 | $279,000 | 0.05% |
| Private Wealth Partners, LLC | 150,000 | $209,000 | 0.02% |
| Phoenix Holdings Ltd. | 317,138 | $426,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 255,300 | $355,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 157,933 | $226,000 | 0.01% |